A plain-language look at what VIP is, where it acts, and what recent research says about its neural and immune roles.
Free research checklist
Medical Disclaimer
This content is for informational and research purposes only and is not intended as medical advice. Always consult with a qualified healthcare professional before making decisions about peptide use or any medical treatment. Individual results may vary.
VIP (Vasoactive Intestinal Peptide): Research Overview
Vasoactive intestinal peptide, or VIP, is a small signaling peptide with a wide reach. It is described in recent sources as a neuropeptide that works as both a neuromodulator and a neurotransmitter. It is also tied to many tissues beyond the gut, including the brain, pancreas, and respiratory tract. In current research, VIP keeps showing up in studies of brain circuits, immune signaling, and tissue regulation.
- VIP is a 28-amino-acid peptide with broad signaling roles in the body.
- Recent sources describe it as a neuromodulator and neurotransmitter, not just a gut peptide.
- New neuroscience work links VIP-expressing neurons to circuit activity and learning-related processing.
- Older and current sources both point to immune, respiratory, and digestive effects, but the evidence is still context-specific.
What VIP is
VIP stands for vasoactive intestinal peptide, also called vasoactive intestinal polypeptide. One source describes it as a peptide hormone of 28 amino acid residues in the glucagon/secretin superfamily. It is also presented as a ligand of class II G protein-coupled receptors. That matters because it places VIP in a signaling family that can affect many organs and cell types, not just the digestive tract.
In a Feb. 4, 2026 UpToDate entry, VIP is described as a neuropeptide that functions as both a neuromodulator and a neurotransmitter. That framing is useful because it reflects how VIP is now viewed in modern biology: not as a narrow gut factor, but as a broader signaling molecule with effects in the nervous system and beyond.
VIP has also been reported in multiple tissues, including the gut, pancreas, neocortex, and suprachiasmatic nuclei of the hypothalamus. Those locations are a clue to its range. The gut points to secretion and smooth muscle effects. The brain points to circuit activity, rhythm, and behavior. The pancreas and respiratory tract point to organ-level regulation.
Where VIP acts
Gut and digestive tract
VIP was first and remains most closely associated with the intestine. The name itself points there. The research bundle describes VIP as affecting water and electrolyte secretion in the intestine, relaxing enteric smooth muscle, dilating peripheral blood vessels, stimulating pancreatic bicarbonate secretion, and inhibiting gastrin-stimulated gastric acid secretion. Another source notes smooth muscle relaxation in the lower esophageal sphincter, stomach, and gallbladder, along with water movement into pancreatic juice and bile.
These are classic secretory and relaxation effects. In plain terms, VIP helps loosen smooth muscle and supports fluid movement. That is why it has long been viewed as important in digestive physiology. A 2020 Nature article in the bundle also notes that VIP appears to matter in inflammatory bowel disease, with mast cell and VIP communication in colitis described as upregulated in Crohn’s disease.
Heart and blood vessels
VIP is also described as vasoactive in the cardiovascular sense. One source says it causes vasodilation and can have positive inotropic and chronotropic effects in the heart. Another notes coronary vasodilation and lower arterial blood pressure. These effects fit the peptide’s name. They also show that VIP is not confined to one organ system. It can influence vessel tone and cardiac activity.
Respiratory tract
The bundle includes a source pointing to VIP in the respiratory tract. The material does not give a full mechanistic map here, but it is enough to show that VIP is not limited to the gut or brain. The respiratory system is another site where its smooth muscle and signaling actions may matter.
Brain
Recent neuroscience work makes VIP especially interesting. In a 2026 Neuron paper, Yang Q and Baror-Sebban used all-optical electrophysiology to study excitation and inhibition in the hippocampus, and the title itself highlights behavior-dependent dynamics. Another 2019 Neuron study cited in the research bundle reported that vasoactive intestinal polypeptide-expressing interneurons in the hippocampus support goal-oriented spatial learning. Together, these sources point to a real role for VIP-expressing interneurons in shaping how hippocampal circuits behave.
The bundle also includes a J Neurosci paper from May 6, 2026, on inhibitory neurons in deviance sound detection in regular and random statistical contexts. While the title does not focus on VIP alone, it fits the broader theme: VIP-linked inhibitory circuits are being studied in behaviorally relevant sensory processing.
There is also older context in the bundle suggesting that VIP is present in normal nervous tissue and neural cell lines. That long-standing observation helps explain why VIP remains a focus in systems neuroscience today.
What recent research suggests
VIP is being studied as a circuit-level modulator
The strongest recent theme in the bundle is that VIP is more than a general signaling peptide. It appears to participate in local circuit control. In the hippocampus, VIP-expressing interneurons are tied to goal-oriented spatial learning and behavior-dependent dynamics of excitation and inhibition. That matters because learning is not just about one neuron firing. It is about how networks shift between excitation and inhibition in real time.
This makes VIP relevant to modern neuroscience questions about how the brain filters input, chooses what to encode, and adapts to changing demands. The research does not support simple one-way claims such as “VIP improves memory” or “VIP increases inhibition.” Instead, it points to a nuanced role in circuit balance.
VIP is also linked to inflammation and immune signaling
The immune side of VIP is a major thread in the bundle. A PMC review from 2015 is included under the title The Neuropeptide VIP: Direct Effects on Immune... The title alone supports the point that VIP has direct immune actions. The Nature article from 2020 adds a specific inflammatory bowel disease context. A 2020 review cited in that source also connects inflammation and depression, which reflects a broader interest in how inflammatory signaling interacts with mood and brain function.
Another May 2026 paper in the bundle looks at severe pancreatitis and intestinal mucosal barrier protection, immune function, and dysbiosis. That paper is not about VIP itself, but its presence in the research set underscores how often VIP is discussed alongside gut-immune stability and inflammatory injury.
VIP sits at the intersection of sleep, circadian, and neural regulation
One of the bundle items is a patient information PDF for VIP that says it is typically administered in the morning or early afternoon to align with its natural role in regulating circadian rhythms, energy levels, and cellular... The source snippet is incomplete, so it should not be pushed too far. Still, it reflects a common research and clinical framing: VIP is connected to rhythm and timing biology.
That idea fits with the mention of the suprachiasmatic nuclei of the hypothalamus, the brain’s main circadian clock center. Even without overclaiming, the sources support a view of VIP as part of time-based physiological regulation.
What not to overstate
VIP is important, but the sources do not justify simple hype. Its effects are context dependent. A peptide that relaxes smooth muscle in one tissue may participate in inhibition or network coordination in another. A peptide that supports one type of immune signaling may behave differently in a different inflammatory state. That is why broad claims about VIP “fixing” sleep, immunity, or inflammation would go beyond the evidence provided here.
The research also does not support treating VIP as a stand-alone answer to complex disease. The bundle includes studies that connect VIP to neurobiology, immune function, and gut physiology, but the evidence is still a mix of review articles, older foundational work, and new circuit-level neuroscience. That means the most accurate summary is that VIP is a multi-system signaling peptide with active research interest, not a settled therapeutic story.
It is also useful to separate biological evidence from public-facing content. The bundle includes a YouTube video titled VIP: The Powerful Peptide for Inflammation, Immunity, and Sleep with 29 views. That view count is concrete, but the title is not evidence. It should not outweigh peer-reviewed sources. The same caution applies to general web summaries that describe VIP in broad, simplified terms.
How VIP fits with other peptide research
VIP is part of a wider peptide landscape that includes related neuropeptides such as PACAP. The bundle’s 2005 review on PACAP, VIP, and PHI notes that these neuropeptides are discussed together in neuroprotective contexts. That is useful because it shows how VIP is often studied not in isolation, but as part of a family of signaling molecules with overlapping or neighboring functions.
In research practice, that means VIP sits at the crossroads of systems biology. It can be examined through the lens of gut secretion, vascular tone, immune regulation, or hippocampal network dynamics. Each lens reveals a different part of the same peptide’s role.
FAQ
What is VIP?
VIP is vasoactive intestinal peptide, also called vasoactive intestinal polypeptide. It is a 28-amino-acid signaling peptide described in recent sources as a neuropeptide, neuromodulator, and neurotransmitter.
Where is VIP found?
The bundle says VIP is produced in many tissues, including the gut, pancreas, neocortex, and suprachiasmatic nuclei of the hypothalamus. That distribution helps explain its broad effects.
What does VIP do in the gut?
VIP is linked to smooth muscle relaxation, water and electrolyte secretion, pancreatic bicarbonate secretion, inhibition of gastric acid secretion, and vascular dilation in the digestive tract.
Why is VIP important in neuroscience?
Recent studies in the bundle connect VIP-expressing interneurons to hippocampal circuit dynamics, goal-oriented spatial learning, and behavior-dependent excitation and inhibition. That makes VIP relevant to how neural networks process information.
Is VIP only a digestive peptide?
No. The research bundle shows roles in the gut, heart, blood vessels, respiratory tract, immune signaling, and brain circuits. Its name comes from the intestine, but its biology is much broader.
Does the research support strong clinical claims about VIP?
No. The sources support a broad biology of VIP, but they do not justify simple claims that it can treat sleep, inflammation, or other conditions on its own. The evidence is context specific and still developing.
Medical Disclaimer
This content is for informational and research purposes only and is not intended as medical advice. Always consult with a qualified healthcare professional before making decisions about peptide use or any medical treatment. Individual results may vary.
About the Author
noia
Researcher
Research specialist focused on peptide science and evidence-based analysis.
References
References for this article are being compiled. Our research team maintains strict standards for peer-reviewed sources.
For specific questions about sources or to suggest additional research, please contact research@peptok.ai
Before the next article
Build your peptide research checklist
Get Peptok's source-quality field guide plus the Monday research brief for article updates, regulatory signals, and evidence notes.